Showing results (411-420 of 428) with videos related to
Sort By:
Pageof 43
Chemistry & Biodiversity|September 11, 2024
Molecular Docking and Antibacterial Activity of Campesterol Derivatives Against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa Multiresistant StrainsCícera D de Morais Oliveira-Tintino, Francisco E F da Silva, Gilvandete M P Santiago, et al.Scientific Reports|November 30, 2022
Analysis toxicity by different methods and anxiolytic effect of the aqueous extract Lippia sidoides ChamCicera J Camilo, Débora O D Leite, Johnatan W da S Mendes, et al.Journal of Biomolecular Structure & Dynamics|March 17, 2023
Hypoglycemic effect of <i>Coffea arabica</i> leaf extracts and major bioactive constituentsG O Nascimento, S P D Marques, C E G Maia, et al.Scientific Reports|May 15, 2024
Enhancing diagnostic accuracy of multiple myeloma through ML-driven analysis of hematological slides: new dataset and identification model to support hematologistsCaio L B Andrade, Marcos V Ferreira, Brenno M Alencar, et al.Scientific Data|January 27, 2025
PCMMD: A Novel Dataset of Plasma Cells to Support the Diagnosis of Multiple MyelomaCaio L B Andrade, Marcos V Ferreira, Brenno M Alencar, et al.Microbial Pathogenesis|August 4, 2022
Anti-inflammatory effect, antibiotic potentiating activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, and evaluation of antibiotic resistance mechanisms by the ibuprofen derivative methyl 2-(-4-isobutylphenyl)propanoateMaria R Xavier, Thiago S Freitas, Raimundo L S Pereira, et al.The Journal of Clinical Endocrinology and Metabolism|March 13, 2019
Enteroendocrine Connections in Congenital Isolated GH Deficiency Due to a GHRH Receptor Gene MutationAlécia A Oliveira-Santos, Roberto Salvatori, Monica C Nogueira, et al.Frontiers in Microbiology|October 25, 2017
Comparative Genomics of Sibling Species of <i>Fonsecaea</i> Associated with Human ChromoblastomycosisVania A Vicente, Vinícius A Weiss, Amanda Bombassaro, et al.The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.Future Medicinal Chemistry|July 12, 2023
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main protease inhibitorsVinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.Pageof 43